Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Congenital cavernous angioma exhibits a progressive decrease in size after birth.

Shigeto Hayashi1, Takeshi Kondoh, Akitsugu Morishita

  • 1Department of Neurosurgery, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, 650-0017, Chuo-ku, Kobe, Japan.

Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery
|January 6, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A multicenter randomized phase II/III trial of salvage treatment for refractory primary central nervous system lymphoma using tirabrutinib: JCOG2314 (ReSTART).

Japanese journal of clinical oncology·2026
Same author

Rapid immunohistochemistry for intraoperative differentiation between high-grade gliomas and primary central nervous system lymphomas: a multicenter prospective study.

Brain tumor pathology·2026
Same author

Long-term clinical outcomes and recurrence factors in intracranial germinoma.

Journal of neuro-oncology·2026
Same author

Cerebrospinal fluid soluble protein tyrosine phosphatase receptor type Z detected with human natural killer-1 antibody as a practical biomarker for glioma diagnosis.

Neuro-oncology advances·2026
Same author

Soluble TIM-3 and galectin-9 serve as additional diagnostic biomarkers in primary central nervous system lymphoma.

Journal of neurology·2026
Same author

Clinical outcomes and MRI-based neurotoxicity assessment of elderly primary CNS lymphoma.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2026

Congenital intracranial cavernous angiomas can spontaneously decrease in size. This case suggests thrombosis, not hemorrhage, is a key mechanism for size reduction in these brain vascular malformations.

Area of Science:

  • Neurology
  • Pediatric Neurosurgery
  • Vascular Malformations

Background:

  • Congenital intracranial cavernous angiomas are rare brain vascular malformations.
  • Hydrocephalus is a common associated condition requiring prompt management.
  • The natural history and regression mechanisms of these lesions remain incompletely understood.

Observation:

  • A case of congenital intracranial cavernous angioma identified in utero at 34 weeks gestation.
  • Postnatal management included external drainage and ventriculoperitoneal shunt for hydrocephalus.
  • Serial CT scans revealed progressive size reduction of the angioma from birth to 8 months.
  • Histopathological analysis confirmed cavernous angioma with evidence of vessel thrombosis and hyaline changes.

Findings:

Related Experiment Videos

  • The intracranial cavernous angioma demonstrated significant spontaneous size decrease over 8 months.
  • No evidence of hemorrhage was detected on serial CT imaging.
  • Histopathology revealed thrombosis within the cavernous vessels as a prominent feature.

Implications:

  • This case suggests spontaneous thrombosis, potentially due to low perfusion, as a primary mechanism for cavernous angioma regression.
  • Understanding these regression mechanisms may influence future management strategies for congenital intracranial cavernous angiomas.
  • Further research into the pathophysiology of thrombosis in these lesions is warranted.